Table 1.
Demographic and Clinical Characteristics of the 46 Patients with Asthma.*
| Characteristic | Value |
|---|---|
| Demographic | |
| Age | 41.5±17.0 |
| Female sex (%) | 80 |
| Race (%)† | |
| White | 62 |
| Black | 23 |
| Other | 15 |
| Clinical | |
| FEV1 at baseline (liters) | 2.1±0.8 |
| FEV1 (% of predicted) | 67.0±16.9 |
| Improvement in FEV1 (%) | 21.9±9.9 |
| Baseline score on Asthma Control Questionnaire‡ |
1.8 |
| Asthma maintenance medication (% of patients) |
|
| None | 49 |
| Inhaled glucocorticoid only | 23 |
| LABA | 0 |
| Leukotriene modifier only | 0 |
| Inhaled glucocorticoid and LABA | 13 |
| Inhaled glucocorticoid and leuko- triene modifier |
2 |
| Inhaled glucocorticoid, LABA, and leukotriene modifier |
13 |
*
Plus–minus values are means ±SD. FEV1 denotes forced expiratory volume in 1 second, and LABA long-acting beta agonist.
†
Race was self-reported.
‡
The scores ranged from 0 to 10, with 0 indicating no improvement and 10 indicating complete improvement.